OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Psychiatry is 68. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	931
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	526
Assumptions and Limitations of the Synthetic Control Method	376
Error in Results	326
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	252
JAMA Psychiatry	246
An Opportunity to Advance Cannabis Science—DEA Rescheduling	243
Potential Lessons for DSM From Contemporary Philosophy of Science	230
Overmystifying the Psychedelic Experience	218
JAMA Psychiatry	191
Polygenic Contributions to Lithium Augmentation Outcomes in Unipolar Depression	191
Integrating Financing Variables Into Behavioral Health Policy Implementation Research	183
Brief Cognitive Behavioral Therapy for Suicidal Military Personnel and Veterans	182
JAMA Psychiatry	182
The Reliability of Traumatic and Adverse Experiences	169
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	166
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	155
Managerial and Organizational Challenges in the Age of AI	138
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	137
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	133
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	129
Diagnosing and Treating ADHD in Adults	127
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	125
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	124
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	123

Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	121
Error in Abstract	118
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	117
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	116
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	115
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	113
Errors in Figures 1 and 2	111
JAMA Network Call for Papers on Health and the 2024 US Election	110
JAMA Psychiatry	108
JAMA Psychiatry	105
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	102
Error in Byline	100
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	98
Searching the Brain for the Cause of Psychosis	96
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	95
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	95
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	94
Addiction Medicine Physicians and Medicinal Cannabinoids	92
Living Alone and Drug Overdose Deaths in the US	92
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	89
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	89
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	88
Hyperalgesia in Patients With a History of Opioid Use Disorder	87
The Role of Energy Homeostasis in Depression Pathophysiology and Its Heterogeneity	85
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	84
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	82
Perinatal Mental Health Outcomes Following Natural Disasters	80
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	78
JAMA Psychiatry—The Year in Review, 2021	78
Errors in Figures 3, 4, and 5	78
Associating Violence With Schizophrenia—Risks and Biases—Reply	78
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	77
JAMA Psychiatry	76
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	75
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	75
Expanding Current Approaches to Solve the Opioid Crisis	74
Measures of General Intelligence and Risk for Alcohol Use Disorder	73
Physician Suicide and Associated Features—What Defines a Physician?	72
JAMA Psychiatry	72
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	72
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	71
Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder	68
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	68
Trends in Outpatient Psychotherapy Among Adults in the US	68
War Exposure and DNA Methylation in Syrian Refugee Children and Adolescents	68
Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression	68